Q2 Solutions (NC, USA) and LGC (Cambridge, UK) have announced a strategic global bioanalytical partnership between the two companies.
In this In the Zone feature we put HRMS versus QqQ in a head to head comparison over a wide range of application areas. Find out the advantages and disadvantages of HRMS and QqQ for small and large molecule bioanalysis.
Join LGC scientists in the grudge match debate direct from Cambridge (UK) to decide the new king of quantitation.
In this series of presentations, LGC (Cambridge, UK) explores whether high resolution mass spectrometry (HRMS) can challenge the ‘Gold Standard’ triple quadrupole mass spectrometer for quantitative bioanalysis within the CRO environment.
LGC (Cambridge, UK) have become the first bioanalytical CRO in Europe to offer the Quanterix Simoa HD-X automated analyzer in a regulated environment.
With vast amounts of data being generated it is important to make the right decision when it comes to appropriate cut-points. In this presentation, Alexandra Hawes (Principal Scientist, LGC, UK), outlines the collaborative process in the context of updated recommendations for statistical analyses. She also discusses the importance of the analytical scientists understanding of how the statistical analysis should be applied and its appropriateness for analytical data. Also included in the presentation are three case studies that illustrate the importance of the collaborative relationship between statisticians and scientists.
All immunogenicity assessments present specific challenges. As a contract research organization (CRO), a major challenge we face is related to the lack of harmonization and standardization. Find out more in this editorial from a team at LGC (Cambridgeshire, UK).
Webinar available to view on demand. In this free panel discussion, our experts will provide insights into their own research with immunogenicity including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.
In this interview Alex Hawes (LGC; Cambridge, UK) discusses the topic of immunogenicity. She explains how she developed her first anti-drug antibody analytical method and the platforms LGC use in their immunogenicity sector.
SCIEX announces innovations in their ultra low-flow separation and accurate mass analysis, capillary electrophoresis–mass spectrometry (CESI-MS) technology and LGC announces investment plans in new GMP analytical capability.